Home » Authors » Andrew Saxon, MD

Andrew Saxon, MD

Professor, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Director, Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA. Chair, Council on Addiction Psychiatry.

Articles

ARTICLES

Using Medical Management in Treating Opioid Use Disorder

November 8, 2018

Andrew Saxon, MD

Andrew Saxon, MD Professor, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Director, Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA. Chair, Council on Addiction Psychiatry. Dr. Saxon has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

To set the stage for understanding medical management, we need to go back about 20 years to the inception of the landmark COMBINE Study. This study was a very large clinical trial for alcohol use disorder (AUD) that compared naltrexone, acamprosate, and their combination, and also looked at two behavioral interventions.

Treating Alcohol Use Disorder: A Fact Book (2023)
All the tools and information needed to assess and treat your patients who are struggling with...
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

General Psychiatry
Psychopharm Commandment #6: MAOIs
MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.
Listen now